Screening from the world's largest TCM database for inhibiting DNA repair protein XRCC4

Molecular Simulation

Volumn 37, Issue 6, 2011, Pages 503-509

  Chang, Tung Ti ^a,b   Sun, Mao Feng ^a,b   Chang, Kai Wei ^a   Chen, Hsin Yi ^c   Tsai, Fuu Jen ^b,c   Fisher, Mark ^d   Lin, Jaung Geng ^a   Chen, Calvin Yu Chian ^a,c,d,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

DNA repair; molecular dynamics; stroke; traditional Chinese medicine; XRCC4

Indexed keywords

BINDING AFFINITIES; CANCER CELLS; CANCER TREATMENT; DNA REPAIR; DNA REPAIR PROTEINS; DOUBLE STRAND BREAK REPAIR; FUNCTIONAL SITES; GLYCYRRHIZIC ACID; HYDROPHOBIC INTERACTIONS; IONISING RADIATION; KEY COMPONENT; MOLECULAR DOCKING; MOLECULAR DYNAMICS SIMULATIONS; PROTEIN RESIDUES; RADIATION THERAPY; REPAIR MECHANISM; STROKE; TRADITIONAL CHINESE MEDICINE; XRCC4;

BINDING ENERGY; DISEASES; DNA; HYDROPHOBICITY; IONIZING RADIATION; LEAD COMPOUNDS; MOLECULAR DYNAMICS; PROTEINS; RADIOTHERAPY;

REPAIR;

EID: 79957600138     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2011.554550     Document Type: Article

References (41)

1. L. Zhang, S. Yoo, A. Dritschilo, I. Belyaev, and V. Soldatenkov, Targeting Ku protein for sensitizing of breast cancer cells to DNAdamage, Int. J. Mol. Med. 14 (2004), pp. 153-159.
2. S.J. Collis, M.J. Swartz, W.G. Nelson, and T.L. DeWeese, Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors, Cancer Res. 63 (2003), pp. 1550-1554. (Pubitemid 36373642)
3. P. Calsou, C. Delteil, P. Frit, J. Droulet, and B. Salles, Coordinated assembly of Ku and p460 subunits of the DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment, J. Mol. Biol. 326 (2003), pp. 93-103. (Pubitemid 36279360)
4. J. Gu, H. Lu, B. Tippin, N. Shimazaki, M.F. Goodman, and M.R. Lieber, XRCC4: DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps (vol 26, pg 1010, 2007), EMBO J. 26 (2007), pp. 3506-3507.
5. C.F. Chiu, M.H. Tsai, H.C. Tseng, C.L. Wang, C.H. Wang, C.N. Wu, C.C. Lin, and D.T. Bau, A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients, Oral Oncol. 44 (2008), pp. 898-902.
6. C.Y. Yen, S.Y. Liu, C.H. Chen, H.F. Tseng, L.Y. Chuang, C.H. Yang, Y.C. Lin, C.H. Wen, W.F. Chiang, C.H. Ho, H.C. Chen, S.T. Wang, C.W. Lin, and H.W. Chang, Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan, J. Oral Pathol. Med. 37 (2008), pp. 271-277.
7. H.C. Tseng, M.H. Tsai, C.F. Chiu, C.H. Wang, N.W. Chang, C.Y. Huang, C.W. Tsai, S.Y. Liang, C.L. Wang, and D.T. Bau, Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan, Anticancer Res. 28 (2008), pp. 1687-1691.
8. K.R. Jones, D.A. Gewirtz, S.M. Yannone, S. Zhou, D.G. Schatz, K. Valerie, and L.F. Povirk, Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein, Mol. Cancer Ther. 4 (2005), pp. 1541-1547. (Pubitemid 41556436)
9. H.J. Huang, K.J. Lee, H.W. Yu, C.Y. Chen, C.H. Hsu, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, Structure-based and ligand-based drug design for HER 2 receptor, J. Biomol. Struct. Dyn. 28 (2010), pp. 23-37.
10. T.T. Chang, H.J. Huang, K.J. Lee, H.W. Yu, H.Y. Chen, F.J. Tsai, M.F. Sun, and C.Y.C. Chen, Key features for designing phosphodiesterase-5 inhibitors, J. Biomol. Struct. Dyn. 28 (2010), pp. 309-321.
11. H.J. Huang, K.J. Lee, H.W. Yu, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, A novel strategy for designing the selective PPAR agonist by the "Sum of Activity" model, J. Biomol. Struct. Dyn. 28 (2010), pp. 187-200.
12. C.Y. Chen and C.Y.C. Chen, Insights into designing the dualtargeted HER2/HSP90 inhibitors, J. Mol. Graph. Model 29 (2010), pp. 21-31.
13. H.J. Huang, C.Y. Chen, H.Y. Chen, F.J. Tsai, and C.Y.C. Chen, Computational screening and QSAR analysis for design of AMPactivated protein kinase agonist, J. Taiwan Inst. Chem. Engrs 41 (2010), pp. 352-359.
14. C.Y.C. Chen, Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database, J. Biomol. Struct. Dyn. 27 (2010), pp. 627-640.
15. C.Y.C. Chen, Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors, J. Taiwan Inst. Chem. Engrs 41 (2010), pp. 143-149.
16. C.Y.C. Chen, Chemical engineering research in Taiwan in 2007- 2009, J. Taiwan Inst. Chem. Engrs 41 (2010), pp. 244-245.
17. C.Y. Chen, H.J. Huang, F.J. Tsai, and C.Y.C. Chen, Drug design for Influenza A virus subtype H1N1, J. Taiwan Inst. Chem. Engrs 41 (2010), pp. 8-15.
18. C.Y.C. Chen, Magnolol encapsulated by different acyl chain length of liposomes on inhibiting proliferation of smooth muscle cells, J. Taiwan Inst. Chem. Engrs 40 (2009), pp. 380-386.
19. C.Y.C. Chen, Weighted equation and rules - A novel concept for evaluating protein-ligand interaction, J. Biomol. Struct. Dyn. 27 (2009), pp. 271-282.
20. C.Y. Chen, Y.H. Chang, D.T. Bau, H.J. Huang, F.J. Tsai, C.H. Tsai, and C.Y.C. Chen, Ligand-based dual target drug design for H1N1: Swine Flu - A preliminary first study, J. Biomol. Struct. Dyn. 27 (2009), pp. 171-178.
21. C.Y. Chen, Y.H. Chang, D.T. Bau, H.J. Huang, F.J. Tsai, C.H. Tsai, and C.Y.C. Chen, Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis, Acta Pharmacol. Sin. 30 (2009), pp. 1186-1194.
22. C.Y.C. Chen, Pharmacoinformatics approach for mPGES-1 in antiinflammation by 3D-QSAR pharmacophore mapping, J. Taiwan Inst. Chem. Engrs 40 (2009), pp. 155-161.
23. C.Y.C. Chen, De novo design of novel selective COX-2 inhibitors: From virtual screening to pharmacophore analysis, J. Taiwan Inst. Chem. Engrs 40 (2009), pp. 55-69.
24. C.Y.C. Chen, Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren, J. Taiwan Inst. Chem. Engrs 40 (2009), pp. 36-47.
25. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus, CHARMM - A program for macromolecular energy, minimization, and dynamics calculations, J. Comput. Chem. 4 (1983), pp. 187-217.
26. P.Y. Wu, P. Frit, S. Meesala, S. Dauvillier, M. Modesti, S.N. Andres, Y. Huang, J. Sekiguchi, P. Calsou, B. Salles, and M.S. Junop, Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4, Mol. Cell Biol. 29 (2009), pp. 3163-3172.
27. C.M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites, J. Mol. Graph. Model. 21 (2003), pp. 289-307. (Pubitemid 35441326)
28. Chiang-su hsin i hsüeh yüan, in Chung yao ta tz'u tien, Shanghai Scientific & Technical Publishers, Shanghai, 1977 -78, pp. 1986-2935.
29. M. Blumenthal, W.R. Busse, A. Goldberg, J. Gruenwald, T. Hall, C.W. Riggins, and R.S. Rister, The Complete German Commissio. Monographs: Therapeutic Guide to Herbal Medicines, S. Klein, R.S. Rister, I.V. Trans, eds., Vol. 150, American Botanical Council, Austin, TX, 1998.
30. S. Dharmananda, Salvia and the History of Microcirculation Research in China, Institute for Traditional Medicine, Portland, OR.
31. B.L. Sibanda, S.E. Critchlow, J. Begun, X.Y. Pei, S.P. Jackson, T.L. Blundell, and L. Pellegrini, Crystal structure of an Xrcc4-DNA ligase IV complex, Nat. Struct. Biol. 8 (2001), pp. 1015-1019. (Pubitemid 33101619)
32. C.D. Yoo, S.C. Kim, and S.H. Lee, Molecular dynamics simulation study of probe diffusion in liquid n-alkanes, Mol. Simul. 35 (2009), pp. 241-247.
33. D.X. Li, G.L. Chen, B.L. Liu, and Y.S. Liu, Molecular simulation of -cyclodextrin inclusion complex with 2-phenylethyl alcohol, Mol. Simul. 35 (2009), pp. 199-204.
34. F. Luan, H.T. Liu, Y. Gao, and X.Y. Zhang, QSPR model to predict the thermal stabilities of second-order nonlinear optical (NLO) chromophore molecules, Mol. Simul. 35 (2009), pp. 248-257.
35. J.H. Jing, G.Z. Liang, H. Mei, S.Y. Xiao, Z.N. Xia, and Z.L. Li, Quantitative structure-mobility relationship studies of dipeptides in capillary zone electrophoresis using three-dimensional holographic vector of atomic interaction field, Mol. Simul. 35 (2009), pp. 263-269.
36. A.M. Al-Mekhnaqi, M.S. Mayeed, and G.M. Newaz, Prediction of protein conformation in water and on surfaces by Monte Carlo simulations using united-atom method, Mol. Simul. 35 (2009), pp. 292-300.
37. M.L. Mihajlovic and P.M. Mitrasinovic, Applications of the ArgusLab4/AScore protocol in the structure-based binding affinity prediction of various inhibitors of group-1 and group-2 influenza virus neuraminidases (NAs), Mol. Simul. 35 (2009), pp. 311-324.
38. K. Roy and G. Ghosh, QSTR with extended topochemical atom (ETA) indices. 11. Comparative QSAR of acute NSAID cytotoxicity in rat hepatocytes using chemometric tools, Mol. Simul. 35 (2009), pp. 648-659.
39. P. Nimmanpipug, V.S. Lee, P. Wolschann, and S. Hannongbua, Litchi chinensis-derived terpenoid as anti-HIV-1 protease agent: Structural design from molecular dynamics simulations, Mol. Simul. 35 (2009), pp. 673-680.
40. P. Ghosh and M.C. Bagchi, Comparative QSAR studies of nitrofuranyl amide derivatives using theoretical structural properties, Mol. Simul. 35 (2009), pp. 1185-1200.
41. Y.S. Zhao, Q.C. Zheng, H.X. Zhang, H.Y. Chu, and C.C. Sun, Homology modelling and molecular dynamics study of human fatty acid amide hydrolase, Mol. Simul. 35 (2009), pp. 1201-1208.